Panteleimon D Mavroudis

Panteleimon D Mavroudis

Sanofi US - New Jersey / United States
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 4388750
-
person_outline Panteleimon D Mavroudis's MOST POPULAR ARTICLES
1-) Phase IIa trial in Duchenne muscular dystrophy shows vamorolone is a first-in-class dissociative steroidal anti-inflammatory drugLS Conklin, JM Damsker, EP Hoffman, WJ Jusko, PD Mavroudis, ...Pharmacological research 136, 140-150, 2018712018
2-) Entrainment of peripheral clock genes by cortisolPD Mavroudis, JD Scheff, SE Calvano, SF Lowry, IP AndroulakisPhysiological genomics 44 (11), 607-621, 2012692012
3-) Systems biology of circadian-immune interactionsPD Mavroudis, JD Scheff, SE Calvano, IP AndroulakisJournal of innate immunity 5 (2), 153-162, 2013612013
4-) Modeling autonomic regulation of cardiac function and heart rate variability in human endotoxemiaJD Scheff, PD Mavroudis, SE Calvano, SF Lowry, IP AndroulakisPhysiological genomics 43 (16), 951-964, 2011632011
5-) Circadian characteristics of permissive and suppressive effects of cortisol and their role in homeostasis and the acute inflammatory responsePD Mavroudis, SA Corbett, SE Calvano, IP AndroulakisMathematical biosciences 260, 54-64, 2015462015